BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 7, 2011
View Archived Issues
Findings reported from REFLEX and MOSAIC trials of IFN-beta1a
Read More
Final results available of first OvaSave trial in Crohn's disease
Read More
Two PentaStaph vaccine components are immunogenic in phase I/II testing
Read More
Study compares Merck & Co. 15-valent pneumococcal conjugate vaccine to Prevnar
Read More
Roche presents highlights of third quarter 2011
Read More
Shigamabs well tolerated to date in phase II trial
Read More
Shire reviews developments of third quarter 2011
Read More
XTL Biopharmaceuticals set to acquire technology being developed for cartilage-related diseases
Read More
OXiGENE discloses final data from FALCON study
Read More
Randomization begins in phase IIb study of Jennerex's JX-594 in advanced liver cancer
Read More
Pfizer returns worldwide rights to TNF-alpha-targeted Nanobodies
Read More
Novel radioprotective agents divulged by Peter MacCallum Cancer Centre
Read More
Merck & Co. discloses new fatty-acid amide hydrolase 1 inhibitors
Read More
CancerTYPE ID test can improve outcome of patients with cancer
Read More
Verseon presents novel thrombin inhibitors
Read More
Rexahn Pharmaceuticals presents phase IIb data on Serdaxin
Read More
New GPR119 receptor agonists claimed
Read More
RegeneRx announces phase II RGN-259 data
Read More
FDA finds no link between ADHD medications and adverse cardiovascular events
Read More
Arena Pharmaceuticals patents new molecules for type 2 diabetes and obesity
Read More
Ongoing phase IIa trial in hepatitis C adds four treatment arms
Read More
Pfizer files application in Japan seeking approval for new indication of Sutent
Read More
FDA approves Bayer's Xarelto for new indication
Read More
FDA provides update on safety review of TNF blockers
Read More
SYGNIS' AXIS 2 trial advances
Read More